Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NUH
|
|||
| Drug Name |
Hm61713
|
|||
| Indication | Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H26N6O2S
|
|||
| Canonical SMILES |
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4
|
|||
| InChI |
1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)
|
|||
| InChIKey |
FDMQDKQUTRLUBU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1353550-13-6
|
|||
| PubChem Compound ID | ||||
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Olmutinib: First Global Approval. Drugs. 2016 Jul;76(11):1153-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.